Purified recombinant Human ApoSAA1 protein Expression System: E.coli Bioactivity: Determined by its ability to chemoattract human monocytes using a concentration range of 10.0-10.0 ng/mL.
SAA1
Spezies: Human
Wirt: Escherichia coli (E. coli)
Recombinant
> 95 % as determined by SDS-PAGE and Coomassie blue staining
Func, AbP, STD, PI
Active
PIG4 Protein, SAA Protein, SAA2 Protein, TP53I4 Protein, zgc:103580 Protein, SAA1 Protein, Saa-1 Protein, Saa2 Protein, serum amyloid A1 Protein, serum amyloid A Protein, amyloid protein A Protein, serum amyloid A protein Protein, serum amyloid a protein Protein, serum amyloid A 1 Protein, serum amyloid protein A Protein, SAA1 Protein, saa Protein, LOC694827 Protein, Sden_2438 Protein, Mmc1_0571 Protein, Riean_0971 Protein, Saa1 Protein, LOC100009168 Protein, LOC101120204 Protein
Hintergrund
Serum amyloid A proteins (SAA) represents a family of apolipoproteins that circulates in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 ug/ml in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid nonglycosylated polypeptide, which contains an 18 amino acid N-terminal sequence. Alternative Names: Apo SAA-1 protein, Human Serum Amyloid A protein, ApoSAA-1, ApoSAA-1 protein, ApoSAA 1 protein, ApoSAA 1, ApoSAA1